这是一篇来自已证抗体库的有关
人类 TACI的综述，是根据11篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合TACI 抗体。
TACI 同义词: CD267; CVID; CVID2; IGAD2; RYZN; TACI; TNFRSF14B
BioLegend
| brown rat 单克隆（1A1） | | BioLegend TACI抗体（BioLegend, 1A1)被用于被用于流式细胞仪在人类样本上 (图 1a). Leukemia (2019) ncbi |
| brown rat 单克隆（1A1） | | BioLegend TACI抗体（BioLegend, 1A1)被用于被用于流式细胞仪在人类样本上 (图 1a). Blood (2018) ncbi |
| brown rat 单克隆（1A1） | | BioLegend TACI抗体（Biolegend, 311912)被用于被用于流式细胞仪在人类样本上 (图 s1c). Eur J Immunol (2018) ncbi |
| brown rat 单克隆（1A1） | | BioLegend TACI抗体（BioLegend, 311906)被用于被用于流式细胞仪在人类样本上 (图 4c). Haematologica (2016) ncbi |
赛默飞世尔
| 小鼠 单克隆（11H3） | | 赛默飞世尔 TACI抗体（eBioscience, 11H3)被用于被用于流式细胞仪在人类样本上. Sci Transl Med (2015) ncbi |
| 小鼠 单克隆（11H3） | | 赛默飞世尔 TACI抗体（eBioscience, 11H3)被用于被用于免疫细胞化学在人类样本上 (图 6). Blood (2015) ncbi |
| 小鼠 单克隆（11H3） | | 赛默飞世尔 TACI抗体（eBiosciences, 11H3)被用于被用于流式细胞仪在人类样本上. J Clin Immunol (2014) ncbi |
安迪生物R&D
| domestic goat 多克隆 | - 抑制或激活实验; 小鼠; 1 ug/ml; 图 4
| 安迪生物R&D TACI抗体（R&D Systems, AF174)被用于被用于抑制或激活实验在小鼠样本上浓度为1 ug/ml (图 4). Leukemia (2016) ncbi |
| 小鼠 单克隆（165604） | - 抑制或激活实验; 人类; 5 ug/ml
- 流式细胞仪; 人类
| 安迪生物R&D TACI抗体（R&D Systems, FAB1741P)被用于被用于抑制或激活实验在人类样本上浓度为5 ug/ml 和 被用于流式细胞仪在人类样本上. J Immunol (2015) ncbi |
| 小鼠 单克隆（165604） | | 安迪生物R&D TACI抗体（R&D Systems, FAB1741P)被用于被用于流式细胞仪在人类样本上. Blood (2009) ncbi |
艾博抗（上海）贸易有限公司
| brown rat 单克隆（1A1） | | 艾博抗（上海）贸易有限公司 TACI抗体（Abcam, 1A1)被用于被用于流式细胞仪在人类样本上. J Clin Immunol (2014) ncbi |
碧迪BD
| brown rat 单克隆（1A1-K21-M22） | | 碧迪BD TACI抗体（BD, 558414)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi |
Tai Y, Lin L, Xing L, Cho S, Yu T, Acharya C,
et al. APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications. Leukemia. 2019;33:426-438
pubmed 出版商 Lee L, Draper B, Chaplin N, Philip B, Chin M, Galas Filipowicz D,
et al. An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma. Blood. 2018;131:746-758
pubmed 出版商 den Hartog G, van Osch T, Vos M, Meijer B, Savelkoul H, van Neerven R,
et al. BAFF augments IgA2 and IL-10 production by TLR7/8 stimulated total peripheral blood B cells. Eur J Immunol. 2018;48:283-292
pubmed 出版商 Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9
pubmed 出版商 Flint S, Gibson A, Lucas G, Nandigam R, Taylor L, Provan D,
et al. A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia. Haematologica. 2016;101:698-706
pubmed 出版商 Li R, Rezk A, Miyazaki Y, Hilgenberg E, Touil H, Shen P,
et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci Transl Med. 2015;7:310ra166
pubmed 出版商 Saulep Easton D, Vincent F, Quah P, Wei A, Ting S, Croce C,
et al. The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells. Leukemia. 2016;30:163-72
pubmed 出版商 García Carmona Y, Cols M, Ting A, Radigan L, Yuk F, Zhang L,
et al. Differential induction of plasma cells by isoforms of human TACI. Blood. 2015;125:1749-58
pubmed 出版商 Hoffmann F, Kuhn P, Laurent S, Hauck S, Berer K, Wendlinger S,
et al. The immunoregulator soluble TACI is released by ADAM10 and reflects B cell activation in autoimmunity. J Immunol. 2015;194:542-52
pubmed 出版商 Barbosa R, Silva S, Silva S, Melo A, Pereira Santos M, Barata J,
et al. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency. J Clin Immunol. 2014;34:573-83
pubmed 出版商 Gupta M, Dillon S, Ziesmer S, Feldman A, Witzig T, Ansell S,
et al. A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation. Blood. 2009;113:5206-16
pubmed 出版商
